Anxiety Disorders
📧 Sign up to get email alerts when something new happens for Anxiety Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-04-11Clinical Trial Update: Cognitive vs. Emotional Psychopharmacological Manipulations of Fear vs. Anxiety [Phase 4]
Phase 4 clinical trial comparing cognitive versus emotional psychopharmacological manipulations for fear and anxiety in individuals with anx…
-
CLINICAL_TRIALS trial_result · 2023-04-11Clinical Trial Update: Pharmacogenomic Testing in Primary Care [NA]
A completed clinical trial updating pharmacogenomic testing in primary care related to antidepressants and adverse effects, with results pos…
-
EMA withdrawal · 2023-03-20EMA Withdrawn: Pregabalin Zentiva k.s. (pregabalin) — Zentiva k.s.
The EMA withdrew pregabalin Zentiva k.s. from the market (Zentiva k.s.) with the therapeutic areas including anxiety disorders, neuralgia, a…
-
FDA approval · 2023-02-08FDA Approved: DIAZEPAM — Supplemental Application (Natco Pharma USA LLC)
FDA approves a supplemental application for Diazepam by Natco Pharma USA LLC, approving a supplemental change to the generic diazepam produc…
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: Neurally Targeted Cognitive Training to Augment CBT Outcomes in Pediatric Anxiety [NA]
A completed clinical trial evaluating neurally targeted cognitive training to augment CBT outcomes in pediatric anxiety disorders; results p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Anxiety in Older Veterans [NA]
Clinical trial update for anxiety disorders in older veterans; study status completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: A Problem Solving Intervention for Hospice Caregivers [NA]
Clinical trial on a problem-solving intervention for hospice caregivers has completed with posted results.
-
FDA approval · 2023-01-17FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for chlordiazepoxide hydrochloride from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2023-01-17FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for diazepam submitted by Hikma Pharmaceuticals USA Inc., marking regulatory action to support t…
-
FDA label_change · 2023-01-17FDA Approved: CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Micro Labs Limited)
The FDA approved a supplemental application for the fixed-dose combination chlordiazepoxide and amitriptyline hydrochloride from Micro Labs …
-
FDA approval · 2023-01-17FDA Approved: DIAZEPAM — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for diazepam oral solution concentrate from Chartwell RX, LLC, adding/confirming approval for this d…
-
FDA approval · 2023-01-17FDA Approved: OXAZEPAM — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Oxazepam (generic) submitted by Actavis Pharma, Inc. (ANDA072253).
-
FDA approval · 2023-01-17FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Diazepam from Hikma Pharmaceuticals USA Inc., indicating an update to an existing Diazepam produ…
-
FDA approval · 2023-01-17FDA Approved: CLONAZEPAM — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' supplemental application for clonazepam, confirming approval of a generic clonazepam product.
-
FDA approval · 2023-01-13FDA Approved: ATIVAN — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for ATIVAN (lorazepam) submitted by Bausch Health US LLC. The action indicates a label update or…
-
FDA approval · 2023-01-13FDA Approved: LOREEV XR — Supplemental Application (Almatica Pharma LLC)
The FDA approved a supplemental application for LOREEV XR (lorazepam) submitted by Almatica Pharma LLC.
-
FDA approval · 2023-01-13FDA Approved: VALIUM — Supplemental Application (Roche Laboratories Inc.)
The FDA approved a supplemental application for Valium (diazepam) from Roche Laboratories Inc., updating the existing NDA.
-
FDA approval · 2023-01-11FDA Approved: DIAZEPAM — Supplemental Application (Natco Pharma USA LLC)
FDA approved a supplemental application for diazepam (generic) from Natco Pharma USA LLC under ANDA210363.
-
CLINICAL_TRIALS trial_result · 2022-12-23Clinical Trial Update: Comparison of Psychotherapy Programs to Treat Panic Disorder [Phase 3]
Phase 3 trial comparing psychotherapy programs for treating Panic Disorder has completed; results posted in 2022.
-
FDA approval · 2022-11-10FDA Approved: DIAZEPAM — Original Application (Fresenius Kabi USA, LLC)
The FDA approved Fresenius Kabi USA, LLC's Original Application for diazepam (generic diazepam). This approval adds a new generic option for…
-
CLINICAL_TRIALS trial_result · 2022-09-09Clinical Trial Update: Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients [Phase 4]
A Phase 4 clinical trial evaluating the efficacy of Exposure and Response Prevention (ERP) and SSRIs in Chinese patients with Obsessive-Comp…
-
FDA approval · 2022-08-09FDA Approved: LORAZEPAM — Supplemental Application (International Medication Systems, Limited)
FDA approves a supplemental application for Lorazepam submitted by International Medication Systems, Limited, enabling its generic formulati…
-
FDA approval · 2022-06-16FDA Approved: CLORAZEPATE DIPOTASSIUM — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' original application for a generic clorazepate dipotassium product.
-
EMA withdrawal · 2022-04-26EMA Withdrawn: Pregabalin Mylan Pharma (pregabalin) — Mylan S.A.S.
EMA withdrawal notice for pregabalin marketed by Mylan S.A.S., affecting anxiety disorders, neuralgia, and epilepsy indications.
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: COVID-19 and the Healthy Minds Program for Educators [NA]
A completed clinical trial evaluating the Healthy Minds Program for Educators in the context of COVID-19, addressing anxiety and depression,…